Presentation
Artificial Intelligence Enables Quantitative Assessment of Ulcerative Colitis Histology
Modern Pathology
Abstract
Ulcerative colitis is a chronic inflammatory bowel disease that is characterized by a relapsing and remitting course. Assessment of disease activity critically informs treatment decisions. In addition to endoscopic remission, histologic remission is emerging as a treatment target and a key factor in the evaluation of disease activity and therapeutic efficacy. However, manual pathologist evaluation is semiquantitative and limited in granularity. Machine learning approaches are increasingly being developed to aid pathologists in accurate and reproducible scoring of histology, enabling precise quantitation of clinically relevant features. Here, we report the development and validation of convolutional neural network models that quantify histologic features pertinent to ulcerative colitis disease activity, directly from hematoxylin and eosin-stained whole slide images. Tissue and cell model predictions were used to generate quantitative human-interpretable features to fully characterize the histology samples. Tissue and cell predictions showed comparable agreement to pathologist annotations, and the extracted slide-level human-interpretable features demonstrated strong correlations with disease severity and pathologist-assigned Nancy histological index scores. Moreover, using a random forest classifier based on 13 human-interpretable features derived from the tissue and cell models, we were able to accurately predict Nancy histological index scores, with a weighted kappa (κ = 0.91) and Spearman correlation (⍴ = 0.89, P < .001) when compared with pathologist consensus Nancy histological index scores. We were also able to predict histologic remission, based on the absence of neutrophil extravasation, with a high accuracy of 0.97. This work demonstrates the potential of computer vision to enable a standardized and robust assessment of ulcerative colitis histopathology for translational research and improved evaluation of disease activity and prognosis.
Read MoreAuthors
Fedaa Najdawi
Kathleen Sucipto
Pratik Mistry
Stephanie Hennek
Christina K.B. Jayson
Mary Lin
Darren Fahy
Shawn Kinsey
Ilan Wapinski
Andrew H. Beck
Murray B. Resnick
Archit Khosla
Michael G. Drage
Kathleen Sucipto
Pratik Mistry
Stephanie Hennek
Christina K.B. Jayson
Mary Lin
Darren Fahy
Shawn Kinsey
Ilan Wapinski
Andrew H. Beck
Murray B. Resnick
Archit Khosla
Michael G. Drage